Balyasny Asset Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.83M Sell
151,856
-35,370
-19% -$2.48M 0.01% 1146
2025
Q4
$17.3M Sell
187,226
-427,133
-70% -$40.9M 0.02% 791
2025
Q3
$45.6M Buy
+614,359
New +$62.2M 0.06% 391
2025
Q1
Sell
-1,895
Closed -$343K 3030
2024
Q4
$351K Buy
+1,895
New +$368K ﹤0.01% 2325
2024
Q3
Sell
-315,098
Closed -$54.7M 2937
2024
Q2
$42.2M Buy
315,098
+238,123
+309% +$45.1M 0.07% 335
2024
Q1
$16.5M Sell
76,975
-23,852
-24% -$4.68M 0.03% 712
2023
Q4
$20.5M Buy
100,827
+83,704
+489% +$13.6M 0.04% 588
2023
Q3
$3.4M Buy
+17,123
New +$4.32M 0.01% 1230
2021
Q4
Sell
-27,250
Closed -$6.35M 2413
2021
Q3
$6.35M Sell
27,250
-147,643
-84% -$30.8M 0.03% 742
2021
Q2
$33.8M Buy
174,893
+167,135
+2,154% +$33.1M 0.16% 154
2021
Q1
$1.61M Buy
+7,758
New +$1.65M 0.01% 1098
2020
Q4
Sell
-31,027
Closed -$4M 1511
2020
Q3
$4M Sell
31,027
-37,800
-55% -$4.17M 0.03% 672
2020
Q2
$5.99M Buy
+68,827
New +$5.29M 0.05% 469
2020
Q1
Sell
-84,939
Closed -$6.3M 1318
2019
Q4
$6.3M Buy
84,939
+78,462
+1,211% +$5.04M 0.04% 536
2019
Q3
$395K Sell
6,477
-144
-2% -$9.48K ﹤0.01% 986
2019
Q2
$402K Buy
6,621
+2,521
+61% +$136K ﹤0.01% 1268
2019
Q1
$233K Buy
+4,100
New +$222K ﹤0.01% 1334

Other funds holding INSP

Balyasny Asset Management's INSP Position: Q1 2026 in Review

Balyasny Asset Management reduced its Inspire Medical Systems (INSP) stake by 19% in Q1 2026, selling an estimated $2.48M and leaving 151,856 shares worth $7.83M. The position accounts for 0.01% of the portfolio, ranked #1146.

Balyasny Asset Management first reported a position in INSP in Q1 2019 and has held it in 17 quarters since. The position peaked at $45.6M in Q3 2025. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • Balyasny Asset Management held 151,856 shares of Inspire Medical Systems worth $7.83M as of Q1 2026.
  • Balyasny Asset Management sold 35,370 Inspire Medical Systems shares in Q1 2026, an estimated $2.48M.
  • Inspire Medical Systems made up 0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1146 holding.
  • Balyasny Asset Management first reported a position in Inspire Medical Systems in Q1 2019 and has held it in 17 quarters since.
  • Balyasny Asset Management's Inspire Medical Systems position peaked at $45.6M in Q3 2025.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.